Browsing: LITESPARK011

Diagnosis

LITESPARK-011 Trial Design and Endpoints

By NewsCancerApril 13, 20260

This segment reviews the design and statistical framework of the LITESPARK-011 trial. The study used dual primary endpoints of progression-free…

Diagnosis

By NewsCancerMarch 31, 20260

This opening segment introduces the Between the Lines discussion of the phase 3 LITESPARK-011 study in advanced clear cell renal…

Survivors

By NewsCancerMarch 31, 20260

In a Between the Lines program following the 2026 ASCO Genitourinary Cancers Symposium, experts convened to discuss findings from the…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.